The current drugs for Parkinson's disease have only limited effects are often accompanied by unwanted side effects. Dutch researchers have developed a new inhibitor that seems very promising.
Scientists at ETH Zurich are researching how cancer drugs can be externally controlled with the aid of magnetic bacteria and thus be guided precisely through the bloodstream to target a tumor.
The dosages of the active substances in the pills can be matched to the needs of each individual patient.
The search for drugs and vaccines against the SARS-CoV-2 virus is in full swing around the world. On a regular basis, there are reports that […]